 Dr
Roland Asmar is Medical Director of The Cardiovascular
Institute，Paris，France，and post-President of the French spoken network of
hypertension.Prior to this position，he was Associate Professor of Therapy
and past president of the Working Group‘Measurement and Evaluation’of the
French Society of Hypertension.Dr Asmar is a member of several prestigious
international committees and scientific societies.Dr Asmar received his
medical degree from Montpellier University.He completed his cardiology and
hypertension residencies at Broussais hospital，received diplomas in non
invasive investigations and ultrasounds，cardiology and vascular diseases
specialist distinction from the French medical board.Dr Asmar developed his
clinical research activities in different research units at the
INSERM（Institut National de la Santé et de la Recherche Médicale），Broussais
Hospital and Paris VI-Pierre et Marie Curie University.He received the
distinction‘Cardiologist of the Year 2001’in France for his Continuous
Medical Education activity.Dr Asmar has published more than 300 scientific
articles and several books in the area of cardiology.Some of his books have
been translated into different languages.He is a consultant and reviewer for
several cardiovascular journals，and has led the organization of several
national and international scientific committees coordinating clinical
trials，and International Consensus Conferences;he is also on the Board of
different medical societies.Dr Asmar principal research interests include
blood pressure measurements，non invasive evaluation of arterial status and
atherosclerosis，cardiovascular clinical intervention trials and development
of new cardiovascular methods and drug agents.
Dear Colleagues,
It is my pleasure and privilege to welcome you to the fifth official
scientific annual ISVH® China meeting which is held in Beijing China on
June 22-28, 2010.
Like previous meetings, the scientific program of this 5th annual
meeting will continue the tradition of high quality scientific program
related to basic and clinical applications of arterial stiffness and
cardiovascular prevention. A large portion of the program will be
devoted to oral presentations and discussions, but it will also include
state-of-the art lectures and workshops.
Vascular health has become a very important issue involved in different
areas such as cardiovascular prevention and management of vascular
diseases going from vascular genesis to the arterial effects of
pharmacological treatment. Recently, the need to assess arterial
stiffness, using pulse wave velocity measurements, has been incorporated
into the European Guidelines for Hypertension Management. Moreover,
results from recent studies are convincing of the need to evaluate
arterial stiffness and central blood pressure as a key parameters in
order to better understand the arterial hemodynamic and drugs effects.
This better understanding of arterial stiffness and central blood
pressure is leading to a clearer explanation of disease pathophysiology
and will shed light on the mechanisms of vascular drugs activities.
The privilege contribution of number of international speakers and
experts coming from China, Hong Kong, Japan, Korea, USA, and Europe will
provide a full update on current international research and views in the
field of arterial evaluation and its clinical applications.
ISVH is grateful to all the sponsors, the Chinese Minister of Health and
Ministry of Civil Affairs, and all the speakers for their support and
contribution to this important meeting. On behalf of the organizing
committee, I Join the president of ISVH® China, Prof. Hongyu Wang, in
giving a warm welcome to the 5th annual ISVH® China week meeting and
look forward to the continued growth of ISVH, and to improving Vascular
Health in patient’s worldwide
Prof Roland Asmar
Chairman
International Society of Vascular Health - ISVH®
Paris- France |
